Talking Euretina
Expert discussions from the world of retina, exploring the latest developments in the field with world-renowned leaders. It features a monthly subspecialty journal club, panel discussions, and interviews with key opinion leaders.
Episodes
Episode 87: Diabetic Tractional Retinal Detachment: Are We Operating Too Late?
Ahead of her Gisbert Richard Lecture at the Euretina Congress in Vienna, Prof. Noemi Lois tells Prof. Nicole Eter why diabetic tractional retinal detachment is far more than a mechanical problem — and why we may be catching patients too late. They discuss the scarce evidence on risk factors, anti-VEGF before vitrectomy, tamponade choices, and what the EMERALD study means for clinic capacity
Episode 86: The Dark Side of the Moon: Prof Frank Holz on Dry AMD and a Career in Retina
Ahead of his EURETINA Lecture in Vienna — "The Dark Side of the Moon: New Horizons in Dry AMD" — Past President Prof. Frank Holz joins President Prof. Nicole Eter for a wide-ranging conversation on his career, from pioneering retinal imaging to restoring central vision in advanced AMD, and why dry AMD may finally be at a turning point. Catch the lecture live in Vienna on Thursday 1 October
Episode 85: Masquerade Syndromes: When Uveitis Isn't Uveitis
In tertiary practice, masquerades account for around 5% of uveitis cases — and missing one can cost sight, or life. Prof Bahram Bodaghi is joined by Prof Elisabetta Miserocchi and Prof Isabelle Audo on vitreoretinal lymphoma, the limits of diagnostic vitrectomy, IL-10:IL-6 ratios and MYD88, the paraneoplastic retinopathies CAR, MAR and BDUMP, and the inherited retinal diseases that quietly mimic i
Episode 84: Inside Euretina Innovation Spotlight: Retina, Industry & Regulators
The Euretina Innovation Spotlight returns to Vienna on 30 September, bringing clinicians, industry, investors and regulators around one table. Prof. Anat Loewenstein, Prof. Nicole Eter and Dr. Kourous Rezaei tell Jonathan McCrea why innovation in retina is moving faster than ever, what the return of the EMA's Jane Mosley means for bridging Europe and the US, and why this exchange of ideas is somet
Episode 83: Retinopathy of Prematurity: Has Anti-VEGF Changed the Game?
Anti-VEGF has transformed how we treat retinopathy of prematurity — but at what long-term cost? Dr Kanmin Xue chairs a global discussion with Dr Domenico Lepore, Prof Wei-Chi Wu and Prof Andreas Stahl on injections versus laser, the RAINBOW and FIREFLEYE trial data, managing peripheral avascular retina, and why these babies may need follow-up for life. A frank look at the questions the evidence ha
Episode 82: Uveal Melanoma in Pregnancy: To Treat or to Wait?
A diagnosis of uveal melanoma during pregnancy forces an agonising question: treat now, or wait? Dr Emine Kiliç chairs a multidisciplinary discussion with Dr Iwona Rospond-Kubiak (Poznań), Prof. Antonia Joussen (Charité, Berlin) and radiation oncologist Dr Adam Chicheł on plaque brachytherapy and fetal radiation exposure, how gestational age shapes timing, and the reassuring — if limited — evidenc
Episode 81: The Women in Retina survey - 5 years on
Euretina will shortly relaunch the Women in Retina survey, building on the first dataset. In this podcast, Prof. Anat Loewenstein, Dr Federica Fossataro and Prof. Nicole Eter explore what has changed since the original 2021 study, what's new and why participation from the whole community - women and men alike - is essential to measuring real progress. The Women In Retina Initiative is sponsored by
Episode 80: Geographic Atrophy: Rethinking Endpoints and Real-World Impact
New therapies are reshaping geographic atrophy—but are trial endpoints keeping pace with clinical reality? Anat Loewenstein is joined by Sobha Sivaprasad and Kristina Pfau to examine how success in GA is measured, from lesion growth to functional vision. The panel explores microperimetry, contrast sensitivity, and emerging tools that may better reflect meaningful patient outcomes.
Episode 79: Decoding Stargardt: New Treatments, Genetics, and What Lies Ahead
A landmark Phase 3 trial has delivered the first positive result for Stargardt disease treatment — but the therapeutic landscape is shifting fast. Prof. Maximilian Pfau enjoys a discussion with Prof. Carel Hoyng and Dr. Karolina Kaminska on the ABCA4 disease spectrum, the groundbreaking discovery of AP5 complex-related macular dystrophy, and emerging therapies from oral drugs to gene-specific appr
Episode 78: Insights from the EURETINA Mentorship Programme
Three former mentees of the EURETINA Mentorship Programme share how the initiative helped shape their careers in retinal research and clinical practice. Özge Yanık Odabaş, Karolina Motloch and Omer Trivizki discuss mentorship, international collaboration, and the opportunities created through the programme’s growing alumni network. Their experiences highlight how structured mentorship can accelera
Episode 77: Implementing AI in Retina Practice: From Screening to Decision Support
Artificial intelligence is rapidly reshaping retina care — but where does it truly add value in daily practice? Professors Tien Wong and Daniel Ting join Stela Vujosevic to explore how AI is moving beyond screening into risk stratification, clinical decision support, and home monitoring. From infrastructure challenges to real-world implementation, this episode offers practical insights for retina
Episode 76: AI in Diabetic Retinopathy: Screening, Biomarkers and What Comes Next
Artificial intelligence is rapidly reshaping how we screen, classify, and treat diabetic retinal disease. Professor Aude Couturier, Professor Edoardo Midena, and Professor Reinier Schlingemann discuss real-world AI applications in diabetic retinopathy — from population screening and imaging biomarkers to phenotyping and precision treatment in diabetic macular oedema
Episode 75: Transitioning from Retina Specialist to Industry
What drives leading retina specialists to trade the clinic for corporate innovation? In this episode, Euretina Board member Kourous Rezaei speaks with Jay Duker (CEO, Eyepoint), Sascha Fauser (SVP, Roche), and Marion Munk (CSO, Gutblick Group; CMO, Isarna Therapeutics) about their transitions from clinical practice to industry. Together they share insights on leadership, research, and the evolving
Episode 74: Intuition in Uncharted Waters: The Art of Retinal Surgery
In this episode Professors Dean Eliott, Grazia Pertile, and José García-Arumí join chair Kourous Rezaei to explore how surgical mastery is built through intuition, preparation, and reflection. They share practical insights on mentorship, focus, teamwork, and managing stressful cases — from avoiding coffee before surgery to resetting after complications — revealing that great surgeons are defined n
Episode 73: When to Treat Small Choroidal Melanomas: A Debate Between Early Intervention and Observation
In this first-ever debate edition of Talking Euretina, Dr Rumana Hussain (Liverpool Ocular Oncology Centre) introduces Professors Arun Singh (Cole Eye Institute, Cleveland Clinic), Heinrich Heimann (Liverpool Ocular Oncology Service) and Bertil Damato (Moorfields Eye Hospital) as they debate one of ocular oncology’s most enduring questions — when to operate on small choroidal melanomas. The panel
Episode 72: Bridging the Gap - Why Diversity in Retina Trials Can’t Wait
Retinal diseases disproportionately affect certain populations—yet these groups are underrepresented in research. In this episode, Dr. Christiana Dinah chairs a global panel including Drs. Adrienne Scott, Charles Wykoff and Jeremiah Brown to explore the systemic and structural barriers to inclusion in retina trials, and why the stakes for equity have never been higher
Episode 71: Restoring Vision with Bionics: Inside the Prima Implant Breakthrough
In this episode, Prof. Frank Holz leads a panel discussion on a major leap forward in retinal prosthesis: the Prima system for geographic atrophy. Joined by Dr. Mahi Muqit and Prof. Lars-Olof Hattenbach, they explore how their extraordinary wireless subretinal implant is restoring visual perception in late-stage AMD.
Episode 70: Highlights from the Euretina Congress 2025 in Paris.
In this episode, Profs. Lejla Vajzovic (USA), Sandrine Zweifel (Switzerland), and Heinrich Heimann (UK) reflect on a fantastic few days in Paris and share their highlights from the 2025 programme for you to watch back through the portal.
Episode 69: Pioneering Retina: Prof. Ursula Schmidt-Erfurth on AI, AMD & 25 Years of Euretina
Euretina President Prof. Anat Loewenstein speaks with Prof. Ursula Schmidt-Erfurth, 25th Euretina Lecturer, about her groundbreaking career in retinal disease, from imaging innovations to AI-driven early detection. They discuss the EU-funded iScreen project, the future of AMD management, and the significance of two women presidents (past and present) as Euretina celebrates its 25th anniversary in
Episode 68: AI, Epidemiology & Innovation: Prof. Korobelnik on the Future of Retina
Ahead of his Gisbert Richard Lecture at this year’s Euretina Congress in Paris, Prof. Jean-François Korobelnik joins Prof. Nicole Eter to reflect on a career at the forefront of retinal research. From surgical breakthroughs to his leadership of the E3 consortium, and his cautious optimism for AI, Prof. Korobelnik shares insights on past progress and future priorities in retina
Episode 67: Throwing Away Wisdom – Maria Berrocal on Saving Proven Treatments for PDR and Retinal Detachment
Ahead of her Kreissig Award Lecture at the Euretina Congress in Paris, Professor Maria Berrocal (Puerto Rico) joins Euretina past president Alistair Laidlaw to discuss why time-tested treatments like PRP and scleral buckling still matter. They explore the risks of over-reliance on anti-VEGF in proliferative diabetic retinopathy, the decline in buckle training, and how chandelier techniques could r
Episode 66: A Holistic Approach? Patient Experience, Mental Health and Emotional Intelligence
In this thought-provoking episode, Professor Tariq Aslam and Retina International’s Avril Daly join Jonathan McCrea to explore the emotional and psychological dimensions of retinal disease. From the power of empathy in clinical care to the need for integrated mental health services, the discussion highlights why supporting patients beyond the medical chart is more vital than ever—especially in an
Episode 65: Decoding White Spot Syndromes: Multimodal Imaging, Challenges & Clinical Clarity
Ahead of her Ophthalmologica Lecture at this year’s Euretina Congress, Dr. Maria Vittoria Cicinelli joins Professor Bahram Bodaghi to explore the evolving understanding of white spot syndromes. From classic presentations of punctate inner choroidopathy (PIC) to emerging imaging insights and therapeutic uncertainties, the conversation highlights unmet needs, research gaps, and practical implication
Episode 64: New Frontiers in Submacular Hemorrhage: Insights from Ophthalmologica
In this episode, Prof. Martin Zinkernagel and Dr. Matias Iglicki spotlight Ophthalmologica’s new article collection on submacular hemorrhages. They explore key findings from four studies covering imaging, surgical strategies, and real-world outcomes, offering timely insights into managing this vision-threatening condition.
Episode 63: Beyond Borders: Navigating Ophthalmology Fellowships Abroad
Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea
Episode 62: Bridging the Gap: How to Make Smarter Ocular Oncology Referrals
When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
Episode 60: Pregnancy, Retina, and Uveitis: Striking the Balance in Challenging Cases
Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the impo
Episode 59: Demystifying Hyperreflective Foci in AMD: From Histology to Imaging
What are hyperreflective foci, and why do they matter in AMD? Prof. Stella Vujosevic is joined by Prof. Christine Curcio (University of Alabama at Birmingham) and Prof. Srinivas Sadda (Doheny Eye Institute, UCLA) to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related ma
Episode 58: Understanding Central Serous Chorioretinopathy: Insights, Challenges, and Future Directions
What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF
Episode 57: Advancing Uveal Melanoma Treatment: Current Strategies and Future Directions
Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Prof Jens Folke Kiilgaard (Denmark) and Dr Emine Kilic (Netherlands) join Prof Antonia Joussen (Germany) to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. W
Episode 56: Intraocular Tamponades and the Athens Special Focus Meeting
In this episode, Chair Alistair Laidlaw (UK) chats to Mario Romano (Italy) and Stratos Gotzaridis (Greece) about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR)
Episode 55: Highlights from the Euretina Congress 2024 Part 3: Arshad Khanani
In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr Arshad Khanani (USA) about clinical trials, long term-data and the importance of personalising the treatment to the patient
Episode 54: Highlights from the Euretina Congress 2024 Part 2: Jean-Francois Korobelnik
In this second episode looking at highlights from the Barcelona congress, we'll hear about AI and sustainability in ophthalmology from Prof Jean-Francois Korobelnik of University Hospital Bordeaux
Episode 53: Highlights from the Euretina Congress 2024 Part 1: Rumana Hussain
Barcelona, We love you! Over the next few episodes, we'll be hearing from 3 different sub-specialty experts about their favourite picks from the excellent Euretina Congress this year. This week, we hear from Ms. Rumana Hussain, Consultant Ophthalmologist specialising in Ocular Oncology and VR surgery at Liverpool University Trust Foundation Hospitals
Episode 52: The Ophthalmologica Lecture: Dr Yousif Subhi
In this episode, Prof Nicole Eter (Germany) speaks with Dr Yousif Subhi, this year's Ophthalmologica lecture about his work in meta-analyses, evidence synthesis, determination of best-practice, and clinical research
Episode 51: The Euretina Lecture: Professor Ohno-Matsui
In this episode, Professor Kyoko Ohno-Matsui discusses advancements in imaging technologies and the management of myopic maculopathy ahead of her keynote lecture at the upcoming Euretina Congress in Barcelona. Chaired by Euretina President, Professor Anat Loewenstein
Episode 50: David Yorston on the Euretina/BEAVRS Database
Ahead of his prestigious Gisbert Richard lecture at this year's upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database
Episode 49: The challenges and opportunities for young retina specialists
In this episode, Drs Kristina Pfau (Switzerland) and Elon Van Dijk (Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They'll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers
Episode 48: Assessing Visual Deficits in Intermediate AMD
In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar, Principal Optometrist at Moorfields and UCL
Episode 47: Gut bacteria and eye disease?
In this podcast, Bart Leroy and Mark Pennesi discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease).
Episode 46: How do you investigate your uveitis patient in 2024?
In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)
Episode 45: Robert J Johnston on Lab-Grown Retinas
In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research? Chaired by Jonathan McCrea
Episode 44: Second Eye Risk: Navigating Prophylaxis in Retinal Detachment, GRT, and Sticklers
In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK)
Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
Episode 42: A Guide to Radiation Maculopathy
In this podcast episode, we will dig into the subject of radiation maculopathy, the most common complication following the irradiation of intraocular tumours, with a panel of ocular oncologists from across Europe: Hibba Quhill (UK), Iwona Rospond-Kubiak (Poland), Emine Kilic (Netherlands) and Raffaele Parrozzani (Italy).
Episode 41: Ophthalmologica spotlight episode
In this episode we look at two very interesting papers published in the latest editions of Ophthalmologica - Martin Busch presents his work on using microRNA as biomarkers for retinal disease and the panel discuss Christina Weisheit's paper on Co2 emissions from the ophthalmic OR. Chaired by Patricia Udaondo, Matias Iglicki and Andreas Ebneter.
Links to papers:
https://karger.com/oph/article/24
Episode 40: Prof David Huang: The co-inventor of OCT
Fresh from his exciting win of the Lasker Award - often dubbed the American Nobel Prize - Professor David Huang (USA) - the inventor of optical coherence tomography (OCT) - joins Prof Pearse Keane (UK) and Tunde Peto (Hungary/UK) to talk about how he and colleagues developed the technology and about the impact it has had on retinal medicine
Episode 39: The Euretina Retinal Medicine Clinical Research Award
As applications open for the Euretina Retinal Medicine Clinical Research Award, we hear about the award from Euretina EVP, Dara Conlon. We also gain interesting insights from previous winners Camiel Boon (Netherlands) and João Pedro Marques (Portugal) to see how the award has furthered their research.
Episode 38: Preview of Euretina Congress 2023
In this podcast Euretina President, Mr Alistair Laidlaw and Euretina EVP Dara Conlon explore the highlights of this year's congress which is on track to be the biggest and most exciting meeting yet!
Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world
In this episode, journalist Ramadan Younis and his executive producer Simon Cox tell us about their far-reaching BBC documentary. "Blind Faith" exposes the international practice of defrauding patients of Retinitis Pigmentosa with false hopes of treatment or cure with little or no evidence of efficacy. They are joined by Prof Robert McLaren of the University of Oxford, who consulted on the documen
Episode 36: The Ophthalmologica Lecture: Maximilian Pfau
In this episode, we’re going to dig into the subject of this year’s Ophtalmologica lecture which will be delivered on the Saturday afternoon at this year’s congress in Amsterdam. Professor Maximilan Pfau is a clinician with a specialism in AMD and Inherited Retinal diseases in the Department of Ophthalmology at the University Eye Hospital, Basel, Switzerland. He's joined by Editor in Chief of the
Episode 35: Treating PCV and Pachychoroid in Different Populations
In this episode, we head to Asia to hear from colleagues in Japan, Singapore and South Korea about their experiences treating PCV and Pachychoroid in different populations. The podcast is chaired by Prof Taiji Sakamoto (Japan) and Prof SeungYoung Yu (South Korea) who are joined by Prof Gemmy Cheung and Prof Adrian Koh (Singapore)
Episode 34: The Euretina Lecture: OncoVR
In this podcast, we hear from Euretina Keynote Bertil Damato (UK/Sweden) about his upcoming talk on OncoVR at the 2023 Euretina Congress. He is joined by colleague Carl Groenewald (UK) and Heinrich Heimann (Chair - UK)
Episode 33: The Euretina Innovation Summit - All You Need to Know
In this podcast, we'll be hearing about an exciting new event taking
place in Amsterdam at the Euretina Congress in October; the inaugural
Euretina Innovation Summit (EIS). Kourous Rezaei (USA) and Anat
Loewenstein (Israel) - two members of the organising committee - will
discuss the programme and motivation behind the event with chair Frank
G Holz (Germany)
Episode 32: Macular Holes and Glaucoma in Myopia
In this podcast, we’ll explore two areas in the subspecialty of myopia: Aude Couturier will share her expertise in macular holes and Dr Yves Lachkar will discuss glaucoma in highly myopic patients. Chaired by David Gaucher and Jost Jonas
Episode 31: Featured studies from the Ophthalmologica journal
In this episode, Editor in Chief at Ophthalmologica, Professor Martin Zinkernagel discusses two featured papers from Euretina’s official journal. The first paper discussed covers choroiditis and the second covers effective treatment regimen in macular degeneration. Faculty are Dr Jeannette Ossewaarde-van Norel and Evianne de Groot (University Medical Center Utrecht) and Mathis Thibaud, Red Cross U
Episode 30: Intraocular Lymphoma: An Explainer
In this episode, we explore how to diagnose and treat intraocular lymphoma with a panel of leading retinal surgeons and oncologists. Dr Hibba Quhill chairs the discussion with Professors Carlos Pavesio and Mandeep Sagoo from Moorfields Eye Hospital, London.
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
In this episode, we will hear all of the tips and tricks to success when looking to submit your research to Ophthalmologica.
Faculty: Martin Zinkernagel (Ophthalmologica editors) and Marco Casola (Karger).
Chaired by Jonathan McCrea
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
In this episode, Edoardo Midena (Italy) chairs a discussion with four leading experts in Diabetic Retinopathy from across the world: Jakob Grauslund (Denmark), Carol Cheung (Hong Kong), Enrico Borrelli (Italy) and Daniel Ting (Singapore)
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
In this episode, Siegfried Priglinger (Germany) and Roxane Hillier (UK) take a look at treatment for macula-off RRD. They're joined by David Yorston (Scotland) and Julian Klaas (Germany) and will ask - how do we best define "macula-off" and when should we start treatment?
Episode 26: Tackling Acute Retinal Necrosis in Patients
Treating rare diseases can sometimes be challenging due a the lack of literature. In this episode, Carlos Pavesio (UK) asks leading experts Sara Touhami (France) and Moncef Khairallah (Tunisia) about their approaches to the diagnosis and treatment of Acute Retinal Necrosis (ARN).
Episode 25: What individual patient data can tell us about treating macular holes
In this podcast, David Steel tells Alistair Laidlaw what he's learned from zeroing in on individual patient data and how factors like posture and hole size affect his decision-making in the treatment of macular holes
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
In this podcast, Mark Penessi is joined by Isabelle Audo and Bart Leroy to discuss the impact of Luxturna and how gene therapy products will affect the treatment of inherited retinal diseases (IRD) in the future.
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
In this episode, Euretina President Alistair Laidlaw chairs a discussion with Nicole Eter (München University Medical Centre) and Brendan Strong, Head of Education at Agenda about the new EBO examination.
Episode 22: Women in Retina
In this podcast, we hear from author and leadership coach Sally Helgesen, author of Why Women Rise about the challenges facing aspiring women leaders. The interview is followed by a discussion with Prof Anat Loewenstein (Israel) and Dr Ruth Freeman (Science Foundation Ireland) about the Women in Retina programme and how to move the dial when it comes to equality of opportunity in medical research.
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
In this in-depth podcast, Euretina President-Elect Ramin Tadayoni (France) chairs a discussion with Kyoko Ohno Matsui (Japan) and David Gaucher (France) exploring everything you need to know when dealing with the “bad guy” in myopia - Staphyloma.
Panel: Prof Ramin Tadayoni, University Of Paris Cite, Lariboisière, Saint Louis And Adolphe De Rothschild Foundation Hospitals, France
Kyoko Ohno Matsu
Episode 20: A Deep Dive into the MOLES System
In this episode, Hibba Quhill (UK) explores each of the components that make up the MOLES system used for management of melanocytic choroidal tumours with the system's originator, Bertil Damato (UK/Sweden).
Episode 19: Exploring the Data from the Derby and Oaks Trials
In this episode we will look at the Derby and Oaks trials; two trials looking at geographic atrophy associated with AMD. The session is chaired by Professor Frank Holz (Germany), featuring Professors Adnan Tufail (UK) and Sandrine Zweifel (Switzerland).
Episode 18: Highlights Continued: The EURETINA Sessions
Worried you missed out on some great content at EURETINA? Don't worry! In this episode, we look back on the best Euretina sessions from the Congress. Joining us to give us their highlights from Hamburg are: Alistair Laidlaw, Euretina President, Ramin Tadayoni (France) and Kourous Rezaei (USA)
Episode 17: Highlights from Euretina Congress in Hamburg
In this episode, we catch up with Professors Camiel Boon, Tunde Peto and Dr Patricia Udaondo (New University and Polytechnic Hospital La Fe, Valencia) fresh from an incredible event in Hamburg to hear all about their highlights of the congress. They'll share their standout sessions that you need to catch up on via the Euretina portal at www.euretina.org
Euretina 2022 Hamburg highlights:
Tunde
Episode 16: Euretina Speaker Spotlight: Prof Hiroko Terasaki and Dr Enrico Borrelli
In this episode, we will again hear from two of our keynote speakers at the Euretina congress in Hamburg this September. Prof Hiroko Terasaki (Japan) who will give the Kreissig Lecture on Sept 3rd at Euretina (interviewed by Professor Ramin Tadayoni, Euretina President Elect) and Dr Enrico Borrelli (Italy) who will give the Ophthalmologica lecture (interviewed by Prof Frank Holz, Bonn, former Eure
Episode 15: Euretina Congress Keynotes
In this episode Euretina President Mr Alistair Laidlaw previews two of our keynote speakers from this year's Euretina Congress in Hamburg. He is joined by Professor Sobha Sivaprasad (UK) and Professor Catherine Creuzot-Garcher (France)
Talking Euretina Summer Break
Talking Euretina is taking a short break but will be back in August
Episode 14: Non-invasive Imaging in Diabetic Retinopathy and Other Retinal Diseases
In this episode, we explore non-invasive imaging of retinal diseases in a discussion chaired by Dr Stela Vujosevic ( Italy). Our faculty are Dr Bianca Gerendas, Medical University of Vienna and Dr Amani Fawzi, Northwestern University of Chicago.
Episode 13: Choroidal Naevi in Daily Practice: Imaging, Follow-ups and the MOLES System
In this episode, we return to the topic of ocular oncology to explore choroidal naevi in daily practice, through Imaging, follow-ups and the MOLES system. This expert discussion is chaired by Heinrich Heimann who is joined by Prof Bertil Damato, Dr Rumana Hussain, Dr Iwona Rospond-Kubiak and Dr Jose Caminal.
Episode 12: Journal Club - Subretinal Hemorrhages and the TIGER study
This Journal Club is all about subretinal hemorrhaging as we take a look at 2 relevant papers and hear the latest developments of the Euretina-sponsored TIGER Study. It is chaired by Professors Grazia Pertile (Sacro Cuore Hospital Negrar, Verona) and Siegfried Priglinger (LMU Munich). They're joined by Professor Timothy Jackson (King’s College, London), Dr Emilia Maggio (Sacro Cuore Hospital Negr
Episode 11: Imaging and AMD - Pathology, Biomarkers and Big Data
In this episode, Professor Sandrine Zweifel (Switzerland) and Professor Adnan Tufail (UK) chair a discussion on how imaging has affected our understanding of AMD. They discuss the impact of new biomarkers and also explore the effect of big data on this field now and into the future. Contributing faculty are Professor Christine Curcio (USA), Professor K Bailey Freund (USA) and Professor Srinivas Sa
Episode 10: Diagnosis and Management of Uveitic Macular Edema
In this episode, Carlos Pavesio (UK) and Sofia Androudi (Greece) share their experience and insights in the diagnosis and treatment of macular edema. Chaired by Bahram Bodaghi (France).
Episode 9: The Importance of Data Storytelling with Brent Dykes
In this episode, we hear from Brent Dykes about the importance of storytelling with data and how to implement it when communicating research. Brent is author of Effective Data Storytelling, founder of Analytics Hero and a regular contributor to Forbes.
Recommended
Bad Friends
The Swerve Podcast: Obscure Topics | Conspiracy Theories
The Bread and Banter Podcast
The Church of What's Happening Now: The New Testament
Deadline: White House
English Vocabulary Help
این نقطه
Solved Murders - True Crime Stories
紐約鳥｜New York Aperture
Doctor Zhivago Slow Read
Apple News In Conversation
The Young and Called Podcast .
